Evidence map›Paper›PMID 40583809›Full record

ArticleClinical and experimental otorhinolaryngology2025

Single-Port Hairline Approach Thyroidectomy in Male Patients: A Retrospective Analysis of Cosmetic and Surgical Outcomes.

Ji Won Kim, Myung Woul Han

Abstract read
In one paragraph

Article in Clinical and experimental otorhinolaryngology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ji Won KimDepartment of Otolaryngology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
Myung Woul HanDepartment of Otolaryngology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesAlthough concerns regarding visible scars have traditionally been associated with female patients, male patients are increasingly placing value on cosmetic outcomes in surgical procedures. Single-port robotic thyroidectomy utilizing a hairline approach has proven feasible in female patients. This study aims to evaluate the safety, utility, and cosmetic results of single-port hairline approach thyroidectomy (SPHAT), with a focus on minimizing visible scarring in male patients.

methodsThirty-one male patients underwent SPHAT performed by a single surgeon between February 2020 and February 2024. We analyzed operative time, complication rates, pain scores (numeric rating scale [NRS]), and cosmetic outcomes in these male patients.

resultsAmong the cases, 27 were diagnosed with papillary thyroid carcinoma, 1 with follicular thyroid carcinoma, 2 with non-invasive follicular neoplasms exhibiting papillary-like nuclear features, and 1 with follicular adenoma. The median age of patients was 62 years (range, 34-73 years). Hemithyroidectomy was conducted in 28 cases and total thyroidectomy in 3 cases. Central neck dissection was performed in 26 cases. The median total operative time was 89 minutes (range, 55-160 minutes), with a median console time of 49 minutes (range, 26-125 minutes). All patients were discharged without major complications on the second or third postoperative day. Postoperative pain NRS scores were 3.71±1.56 on the day of surgery and 2.86±0.35 on the first postoperative day. Six months after surgery, the mean cosmetic satisfaction score on a visual analog scale was 8.51±1.62.

conclusionSPHAT is a viable and safe approach for male patients, offering excellent cosmetic.

results

Indexed as

da Vinci SP Robotic SystemHairlineMaleRobotic Thyroidectomy

Identifiers

PMID40583809
PMCPMC12588049

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.